Article
To kill a cancer: Targeting the immune inhibitory checkpoint molecule, B7-H3
23 Aug 2022
Abstract excerpt
Targeting the anti-tumor immune response via the B7 family of immune-regulatory checkpoint proteins has revolutionized cancer treatment and resulted in punctuated responses in patients. B7-H3 has gained recent attention given its prominent deregulation and immunomodulatory role in a multitude of cancers. Numerous cancer studies have firmly established a strong link between deregulated B7-H3 expression and poorer...
Topics
Join the communities discussing this publication.